Hepatitis A and Hepatitis B (Recombinant) Vaccine

CHEBI:CHEBI_750611

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

listing_expiration_date
20241231
route
INTRAMUSCULAR
dosage_form
INJECTION, SUSPENSION
product_type
VACCINE
marketing_category
BLA
pharm_class
Inactivated Hepatitis A Virus Vaccine [EPC]
labeler_name
GlaxoSmithKline Biologicals SA
active_ingredient_name
HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN
active_ingredient_strength
720 [iU]/mL
generic_name
Hepatitis A and Hepatitis B (Recombinant) Vaccine
brand_name
TWINRIX
brand_name_base
TWINRIX
product_ndc
50090-1645
application_number
BLA103850
marketing_start_date
20070607
package_marketing_start_date
20070607
spl_id
608f8399-db16-4921-b0c8-153b81b1d568
package_ndc
50090-1645-0
package_description
10 SYRINGE in 1 CARTON (50090-1645-0) / 1 mL in 1 SYRINGE (50090-1645-9)
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class